FIORILLO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.682
AS - Asia 956
EU - Europa 921
SA - Sud America 165
AF - Africa 84
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.817
Nazione #
US - Stati Uniti d'America 1.637
SG - Singapore 553
IT - Italia 248
UA - Ucraina 230
CN - Cina 227
DE - Germania 187
BR - Brasile 153
HK - Hong Kong 72
SN - Senegal 67
SE - Svezia 59
FI - Finlandia 47
AT - Austria 46
CA - Canada 37
TR - Turchia 35
FR - Francia 23
KR - Corea 18
IN - India 16
GB - Regno Unito 14
BE - Belgio 13
RU - Federazione Russa 13
NL - Olanda 10
ZA - Sudafrica 9
BD - Bangladesh 7
PL - Polonia 7
ES - Italia 6
IQ - Iraq 6
MA - Marocco 6
AU - Australia 5
CZ - Repubblica Ceca 4
EU - Europa 4
JM - Giamaica 4
JP - Giappone 4
VN - Vietnam 4
AR - Argentina 3
MX - Messico 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EC - Ecuador 2
HU - Ungheria 2
KE - Kenya 2
LT - Lituania 2
PK - Pakistan 2
UZ - Uzbekistan 2
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.817
Città #
Chandler 287
Singapore 190
Jacksonville 137
Boardman 132
New York 125
San Mateo 83
Hong Kong 71
Dakar 67
Dearborn 67
Rende 60
Ashburn 55
Shanghai 50
Beijing 47
Lawrence 44
Roxbury 44
Helsinki 34
Munich 29
Brooklyn 28
Vienna 28
Hefei 26
Izmir 26
Florence 24
Des Moines 21
Ottawa 21
Seattle 21
Los Angeles 19
The Dalles 19
Catanzaro 18
Seoul 18
Brussels 13
Cambridge 13
Inglewood 13
São Paulo 13
Cosenza 12
Guangzhou 11
Ogden 11
Columbus 10
Hanover 10
Turku 10
Wilmington 10
San Francisco 9
Naples 8
Ann Arbor 7
Falkenstein 7
Toronto 7
Bari 6
Bremen 6
Grafing 6
Rome 6
Warsaw 6
Modugno 5
Montreal 5
Norwalk 5
Palermo 5
Pune 5
Santa Clara 5
Wuhan 5
Amsterdam 4
Belo Horizonte 4
Boston 4
Catania 4
Chennai 4
Contagem 4
Council Bluffs 4
Guarulhos 4
Jiaxing 4
London 4
Matera 4
Redmond 4
Tokyo 4
Ankara 3
Baghdad 3
Belvedere Marittimo 3
Berlin 3
Brno 3
Campinas 3
Como 3
Dhaka 3
Düsseldorf 3
Frankfurt am Main 3
Heze 3
Johannesburg 3
Joinville 3
Kingston 3
Lamezia Terme 3
Lappeenranta 3
Manchester 3
Mateus Leme 3
Monmouth Junction 3
Nanjing 3
Phoenix 3
Rabat 3
Redwood City 3
Rio de Janeiro 3
Stockholm 3
São José 3
West Jordan 3
Amantea 2
Anápolis 2
Arequipa 2
Totale 2.159
Nome #
Polyunsaturated Fatty Acids and their Role in the Diet of Cancer Patients: An Overview 143
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism 141
Bergamot (citrus bergamia risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: An overview 122
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 115
Enhanced cellular uptake by "pharmaceutically oriented devices" of new simplified analogues of Linezolid with antimicrobial activity 111
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 108
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 107
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) 104
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 102
Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway 102
Antibacterial activity of new Beta-lactam compounds 101
Characterization of new mitochondrial carriers in Drosophila melanogaster”. 98
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 98
5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer 95
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 95
Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies 93
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 90
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast 87
ERRα PATHWAY AND ENDOCRINE RESISTANCE ON BREAST CANCER: CHOLESTEROL AND MEVALONATE INVOLVEMENT 85
Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy 82
Thioalbamide, a thioamidated peptide from Amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress 81
A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like Mode 79
Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): "In vivo" studies 68
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase 68
New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier 67
GENOMICS-BASED DISCOVERY AND ANTICANCER ACTIVITY ASSESSMENT OF NEW THIOVIRIDAMIDE-LIKE MOLECULES PRODUCED BY ACTINOBACTERIA 66
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production 64
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 61
"Energetic" cancer stem cells (e-CSCs): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy 61
Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) 61
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via "differentiation-based nano-therapy" 58
New simplified analogues of linezolid with antimicrobial activity. 56
Mass Spectrometry-Based Proteomic Approach in Oenococcus oeni Enological Starter 52
Multifunctional Microspheres Based on D-Mannose and Resveratrol for Ciprofloxacin Release 51
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 50
Sntesi ed attività antimicrobica di nuovi derivati b-lattamici 50
New β-Lactam derivatives: synthesis and antimicrobial properties. 50
New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration 49
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 48
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer 45
New Oxazolidin-2-ones with antimicrobial activity 44
Oxazolidinones-mediated mitochondrial dysfunction promotes cell death and cancer stemness inhibition in breast and cervical cancer 43
Two functionally different mitochondrial phosphate carriers support Drosophila melanogaster OXPHOS throughout distinct developmental stages 43
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells 42
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy 42
The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment 39
Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models 38
New Oxazolidin-2-ones of antimicrobial activity 37
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 37
Impact of COVID-19 Lockdown on Metabolic/Inflammatory Profile in Adolescents: Cellular Studies and Predictive Biomarkers 36
Exploiting Glycyrrhiza glabra L. (Licorice) Flavanones: Licoflavanone’s Impact on Breast Cancer Cell Bioenergetics 31
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy 31
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells 31
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 28
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs) 28
Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia 26
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics 22
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 21
Novel CD44-Targeted Albumin Nanoparticles: An Innovative Approach to Improve Breast Cancer Treatment 20
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling 19
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 16
Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy 13
Merging fusogenic DOPE and a tumour targeted self-assembling biopolymer: Smart hybrid liposomes for drug vectorization in cancer therapy 13
Totale 3.964
Categoria #
all - tutte 29.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 34 0 31 37 3 28 3 53 17 28 7 24
2021/2022466 9 61 2 20 45 9 2 98 21 3 68 128
2022/2023746 100 80 21 75 95 50 13 106 93 27 55 31
2023/2024570 65 20 35 16 30 176 20 28 58 33 12 77
2024/20251.208 84 146 17 72 77 65 86 72 187 88 107 207
2025/2026285 285 0 0 0 0 0 0 0 0 0 0 0
Totale 3.964